Am J Surg

1. TELLEZ C, Labro-Ciurans M, de la Serna S, Hernando R, et al
   Postoperative serum VEGF concentration and recurrence after curative colon cancer surgery: findings from a multicenter prospective cohort.
   Am J Surg. 2025;249:116603.
   

   >> Share

   
   

   
   BMC Cancer

2. TOPI G, Sjolander A, Satapathy SR
   Integrating COX-2, stromal PD-L1, and T-cell infiltration enhances prognostic stratification in colorectal cancer.
   BMC Cancer. 2025;25:1424.
   

   >> Share

   
   

   
   Br J Cancer

3. MONTERO-CALLE A, Jimenez de Ocana S, Rejas-Gonzalez R, Benavente-Naranjo R, et al
   Deciphering the central role of TMOD2 in colorectal cancer progression and metastasis.
   Br J Cancer. 2025 Sep 17. doi: 10.1038/s41416-025-03184.
   

   >> Share

   
   

   
   Cancer Res

4. SUN F, Wang K, Dong X, Secaira-Morocho H, et al
   The Microbial Bile Acid Metabolite 3-oxo-LCA Inhibits Colorectal Cancer Progression.
   Cancer Res. 2025 Sep 16. doi: 10.1158/0008-5472.CAN-24-3898.
   

   >> Share

   
   
5. LIU C, Lai P, Hu J, Yin S, et al
   Lactobacillus johnsonii Synthesizes Chenodeoxycholic Acid to Reduce Susceptibility to High-Fat Diet-Induced Colorectal Cancer.
   Cancer Res. 2025 Sep 15. doi: 10.1158/0008-5472.CAN-25-0879.
   

   >> Share

   
   

   
   Dis Colon Rectum

6. GORGUN E, Erozkan K, Karahan SN, Erkaya M, et al
   Expanding Organ Preservation in Locally Advanced Rectal Cancer After Total Neoadjuvant Therapy With Endoscopic Submucosal Dissection.
   Dis Colon Rectum. 2025;68:1172-1182.
   

   >> Share

   
   
7. WAN H, Weng J, Cai J, Chen Z, et al
   Nodal Downstaging in Patients With Rectal Cancer: Survival Is Promising if YpN0 Is Achieved.
   Dis Colon Rectum. 2025;68:1162-1171.
   

   >> Share

   
   
8. FERNANDEZ LM, Vailati BB, Sao Juliao GP, Corbi LE, et al
   Partial Responders to Neoadjuvant Therapy and the Risk of Distant Metastases: Longer Intervals to Definitive Resection Is Not a Risk Factor.
   Dis Colon Rectum. 2025;68:1154-1161.
   

   >> Share

   
   

   
   Int J Cancer

9. HARAGUCHI E, Akiyoshi T, Noguchi T, Sakamoto T, et al
   Differential effects of RAS mutations on chemoradiotherapy and total neoadjuvant therapy in locally advanced rectal cancer.
   Int J Cancer. 2025;157:2146-2155.
   

   >> Share

   
   

   
   Int J Colorectal Dis

10. DAVEY MG, Donlon NE, Donnelly M, Ryan EJ, et al
    Evaluating the influence of the obesity paradox on survival outcomes in patients being treated surgically for rectal cancer-a systematic review and meta-analysis.
    Int J Colorectal Dis. 2025;40:180.
    

    >> Share

    
    
11. JACOPO M, Maximilian S, Gherardo M, Carlo B, et al
    Long-term outcomes of transanal irrigation in patients with low anterior resection syndrome: what happens after more than five years?
    Int J Colorectal Dis. 2025;40:181.
    

    >> Share

    
    
12. MAKSIM R, Buczynska A, Sidorkiewicz I, Mojsak M, et al
    Standard of practice imaging vs. PET/MR: a comparative prospective study in rectal cancer staging.
    Int J Colorectal Dis. 2025;40:198.
    

    >> Share

    
    
13. GOHIL S, D'Attilio D, Paladiya R, Ganguly A, et al
    Adherence to multi-target stool DNA colorectal cancer screening and clinical follow-up in the Hartford HealthCare system.
    Int J Colorectal Dis. 2025;40:200.
    

    >> Share

    
    
14. GENER-JORGE C, Ferreres Pinas JC, Moreno Garcia AB, Melgar Rivera DS, et al
    Interobserver agreement of the Tauli-pT1 classification in rectal pT1 adenocarcinoma.
    Int J Colorectal Dis. 2025;40:201.
    

    >> Share

    
    

    
    N Engl J Med

15. GOLDBERG RM, Meyerhardt JA
    An Aspirin a Day for Improved Colorectal Cancer Outcomes.
    N Engl J Med. 2025;393:1131-1132.
    

    >> Share

    
    
16. MARTLING A, Hed Myrberg I, Nilbert M, Gronberg H, et al
    Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer.
    N Engl J Med. 2025;393:1051-1064.
    

    >> Share

    
    

    
    Oncogene

17. YIN Y, Ming L, Qin Y, Tang J, et al
    RAB22A triggers intercellular chemoresistance transmission in colorectal cancer by promoting exosome release via the PKM2-pSNAP23 axis.
    Oncogene. 2025 Sep 16. doi: 10.1038/s41388-025-03566.
    

    >> Share

    
    

    
    PLoS One

18. READ OJ, Bre J, Zhang Y, Mullen P, et al
    A phosphoramidate modification of FUDR, NUC-3373, causes DNA damage and DAMPs release from colorectal cancer cells, potentiating lymphocyte-induced cell death.
    PLoS One. 2025;20:e0331567.
    

    >> Share

    
    
19. BIE Y, Bie M, Liu W, Tao S, et al
    ZBTB7A regulates CD95-mediated cell growth in colorectal cancer cell lines.
    PLoS One. 2025;20:e0329958.
    

    >> Share

    
    
20. LEE JO, Kim CY, Lee S, Chung JH, et al
    Multi-cancer analysis of histopathologic MSI screening based on digital histology image.
    PLoS One. 2025;20:e0332034.
    

    >> Share

    
    
21. NAES SM, Ab-Rahim S, Mazlan M, Syafruddin SE, et al
    CRISPR/Cas9 mediated ENT2 gene knockout altered purine catabolic pathway and induced apoptosis in colorectal cell lines.
    PLoS One. 2025;20:e0329501.
    

    >> Share

    
    

    
    World J Surg

22. STROMBERG C, Abraham-Nordling M
    Income Level and Survival After Resection of Liver Metastases: A Population-Based Study.
    World J Surg. 2025;49:2578-2584.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share